What seven studies show about detecting cancer from plasma DNA methylation
In the one comparison of cfDNA features on the same participants, whole-genome methylation detected 34% of cancers at 98% specificity and located the tissue better than copy number or mutations. Higher figures come from smaller case-control cohorts. No machine-learning method has beaten the established baseline on the same data.
